nodes	percent_of_prediction	percent_of_DWPC	metapath
Levocabastine—Eye redness—Brimonidine—glaucoma	0.0219	0.0254	CcSEcCtD
Levocabastine—Eye redness—Dorzolamide—glaucoma	0.021	0.0243	CcSEcCtD
Levocabastine—Stinging—Dipivefrin—glaucoma	0.0196	0.0227	CcSEcCtD
Levocabastine—Stinging—Echothiophate—glaucoma	0.0165	0.0191	CcSEcCtD
Levocabastine—Lacrimation—Metipranolol—glaucoma	0.0152	0.0176	CcSEcCtD
Levocabastine—Lacrimation increased—Echothiophate—glaucoma	0.0145	0.0168	CcSEcCtD
Levocabastine—Eyelid oedema—Latanoprost—glaucoma	0.0144	0.0167	CcSEcCtD
Levocabastine—Lacrimation—Carteolol—glaucoma	0.0141	0.0163	CcSEcCtD
Levocabastine—Ocular hyperaemia—Apraclonidine—glaucoma	0.0124	0.0143	CcSEcCtD
Levocabastine—Eyelid oedema—Apraclonidine—glaucoma	0.0115	0.0133	CcSEcCtD
Levocabastine—Eyelid oedema—Bimatoprost—glaucoma	0.0112	0.0129	CcSEcCtD
Levocabastine—Ocular hyperaemia—Brimonidine—glaucoma	0.0106	0.0123	CcSEcCtD
Levocabastine—Ocular hyperaemia—Dorzolamide—glaucoma	0.0101	0.0118	CcSEcCtD
Levocabastine—Ocular hyperaemia—Travoprost—glaucoma	0.0101	0.0117	CcSEcCtD
Levocabastine—Ocular hyperaemia—Brinzolamide—glaucoma	0.00998	0.0116	CcSEcCtD
Levocabastine—Eyelid oedema—Brimonidine—glaucoma	0.00987	0.0114	CcSEcCtD
Levocabastine—Lacrimation—Apraclonidine—glaucoma	0.00987	0.0114	CcSEcCtD
Levocabastine—Stinging—Carbachol—glaucoma	0.00981	0.0114	CcSEcCtD
Levocabastine—Lacrimation increased—Metipranolol—glaucoma	0.0097	0.0112	CcSEcCtD
Levocabastine—Stinging—Levobunolol—glaucoma	0.00966	0.0112	CcSEcCtD
Levocabastine—Lacrimation—Bimatoprost—glaucoma	0.00957	0.0111	CcSEcCtD
Levocabastine—Eyelid oedema—Dorzolamide—glaucoma	0.00943	0.0109	CcSEcCtD
Levocabastine—Eyelid oedema—Travoprost—glaucoma	0.00939	0.0109	CcSEcCtD
Levocabastine—Eyelid oedema—Brinzolamide—glaucoma	0.00927	0.0107	CcSEcCtD
Levocabastine—Lacrimation increased—Carteolol—glaucoma	0.00899	0.0104	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—OPN4—glaucoma	0.00897	0.0657	CbGpPWpGaD
Levocabastine—Stinging—Latanoprost—glaucoma	0.00896	0.0104	CcSEcCtD
Levocabastine—Lacrimation—Brimonidine—glaucoma	0.00847	0.00982	CcSEcCtD
Levocabastine—Lacrimation—Dorzolamide—glaucoma	0.00809	0.00937	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—PTGFR—glaucoma	0.00808	0.0591	CbGpPWpGaD
Levocabastine—Lacrimation—Travoprost—glaucoma	0.00806	0.00933	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00802	0.0587	CbGpPWpGaD
Levocabastine—Lacrimation—Brinzolamide—glaucoma	0.00796	0.00922	CcSEcCtD
Levocabastine—Lacrimation increased—Latanoprost—glaucoma	0.00788	0.00912	CcSEcCtD
Levocabastine—Lacrimation—Pilocarpine—glaucoma	0.00765	0.00886	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00758	0.0555	CbGpPWpGaD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.00722	0.0529	CbGpPWpGaD
Levocabastine—Stinging—Bimatoprost—glaucoma	0.00695	0.00804	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00693	0.0508	CbGpPWpGaD
Levocabastine—Ocular hyperaemia—Betaxolol—glaucoma	0.00667	0.00772	CcSEcCtD
Levocabastine—Visual disturbance—Carteolol—glaucoma	0.00635	0.00735	CcSEcCtD
Levocabastine—Lacrimation increased—Apraclonidine—glaucoma	0.0063	0.00729	CcSEcCtD
Levocabastine—NTSR2—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00624	0.0457	CbGpPWpGaD
Levocabastine—Stinging—Brimonidine—glaucoma	0.00615	0.00712	CcSEcCtD
Levocabastine—Lacrimation increased—Bimatoprost—glaucoma	0.00611	0.00707	CcSEcCtD
Levocabastine—Visual disturbance—Levobunolol—glaucoma	0.006	0.00695	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00594	0.0435	CbGpPWpGaD
Levocabastine—Stinging—Dorzolamide—glaucoma	0.00587	0.0068	CcSEcCtD
Levocabastine—Eye pain—Latanoprost—glaucoma	0.00584	0.00676	CcSEcCtD
Levocabastine—Erythema—Echothiophate—glaucoma	0.00583	0.00675	CcSEcCtD
Levocabastine—Stinging—Pilocarpine—glaucoma	0.00555	0.00643	CcSEcCtD
Levocabastine—Ocular hyperaemia—Timolol—glaucoma	0.00545	0.00631	CcSEcCtD
Levocabastine—Lacrimation increased—Brimonidine—glaucoma	0.00541	0.00626	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00535	0.0392	CbGpPWpGaD
Levocabastine—Lacrimation—Betaxolol—glaucoma	0.00532	0.00616	CcSEcCtD
Levocabastine—Lacrimation increased—Dorzolamide—glaucoma	0.00516	0.00598	CcSEcCtD
Levocabastine—Lacrimation increased—Travoprost—glaucoma	0.00514	0.00595	CcSEcCtD
Levocabastine—Lacrimation increased—Brinzolamide—glaucoma	0.00508	0.00588	CcSEcCtD
Levocabastine—Eyelid oedema—Timolol—glaucoma	0.00506	0.00586	CcSEcCtD
Levocabastine—Lacrimation increased—Pilocarpine—glaucoma	0.00488	0.00565	CcSEcCtD
Levocabastine—Pain—Dipivefrin—glaucoma	0.00485	0.00562	CcSEcCtD
Levocabastine—Eye pain—Apraclonidine—glaucoma	0.00467	0.00541	CcSEcCtD
Levocabastine—Eye pain—Bimatoprost—glaucoma	0.00452	0.00524	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—OPN4—glaucoma	0.00452	0.0331	CbGpPWpGaD
Levocabastine—Lacrimation—Timolol—glaucoma	0.00434	0.00503	CcSEcCtD
Levocabastine—Visual impairment—Metipranolol—glaucoma	0.00433	0.00501	CcSEcCtD
Levocabastine—Visual disturbance—Bimatoprost—glaucoma	0.00431	0.00499	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—PTGFR—glaucoma	0.00407	0.0298	CbGpPWpGaD
Levocabastine—Pain—Echothiophate—glaucoma	0.00407	0.00471	CcSEcCtD
Levocabastine—Visual impairment—Carteolol—glaucoma	0.00401	0.00464	CcSEcCtD
Levocabastine—Eye pain—Brimonidine—glaucoma	0.00401	0.00464	CcSEcCtD
Levocabastine—Nausea—Physostigmine—glaucoma	0.00397	0.00459	CcSEcCtD
Levocabastine—Eye pain—Dorzolamide—glaucoma	0.00383	0.00443	CcSEcCtD
Levocabastine—Visual disturbance—Brimonidine—glaucoma	0.00382	0.00442	CcSEcCtD
Levocabastine—Eye pain—Travoprost—glaucoma	0.00381	0.00441	CcSEcCtD
Levocabastine—Visual impairment—Levobunolol—glaucoma	0.00379	0.00439	CcSEcCtD
Levocabastine—Eye pain—Brinzolamide—glaucoma	0.00376	0.00436	CcSEcCtD
Levocabastine—Visual disturbance—Dorzolamide—glaucoma	0.00365	0.00422	CcSEcCtD
Levocabastine—Eye pain—Pilocarpine—glaucoma	0.00362	0.00419	CcSEcCtD
Levocabastine—Visual disturbance—Brinzolamide—glaucoma	0.00358	0.00415	CcSEcCtD
Levocabastine—Cough—Metipranolol—glaucoma	0.00341	0.00395	CcSEcCtD
Levocabastine—Lacrimation increased—Betaxolol—glaucoma	0.00339	0.00393	CcSEcCtD
Levocabastine—Erythema—Latanoprost—glaucoma	0.00317	0.00368	CcSEcCtD
Levocabastine—Stinging—Timolol—glaucoma	0.00315	0.00365	CcSEcCtD
Levocabastine—Pharyngitis—Apraclonidine—glaucoma	0.00289	0.00335	CcSEcCtD
Levocabastine—Dyspnoea—Metipranolol—glaucoma	0.00284	0.00329	CcSEcCtD
Levocabastine—Somnolence—Metipranolol—glaucoma	0.00284	0.00329	CcSEcCtD
Levocabastine—Visual impairment—Apraclonidine—glaucoma	0.00281	0.00325	CcSEcCtD
Levocabastine—Pharyngitis—Bimatoprost—glaucoma	0.0028	0.00325	CcSEcCtD
Levocabastine—Lacrimation increased—Timolol—glaucoma	0.00277	0.00321	CcSEcCtD
Levocabastine—Visual impairment—Bimatoprost—glaucoma	0.00272	0.00315	CcSEcCtD
Levocabastine—NTSR2—G alpha (q) signalling events—EDN1—glaucoma	0.00269	0.0197	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—EDN1—glaucoma	0.00265	0.0194	CbGpPWpGaD
Levocabastine—Dyspnoea—Carteolol—glaucoma	0.00264	0.00305	CcSEcCtD
Levocabastine—Somnolence—Diclofenamide—glaucoma	0.00258	0.00299	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—OPN4—glaucoma	0.00256	0.0187	CbGpPWpGaD
Levocabastine—Erythema—Apraclonidine—glaucoma	0.00254	0.00294	CcSEcCtD
Levocabastine—Eye pain—Betaxolol—glaucoma	0.00251	0.00291	CcSEcCtD
Levocabastine—Fatigue—Diclofenamide—glaucoma	0.00251	0.0029	CcSEcCtD
Levocabastine—Dyspnoea—Levobunolol—glaucoma	0.00249	0.00288	CcSEcCtD
Levocabastine—Pharyngitis—Brimonidine—glaucoma	0.00248	0.00288	CcSEcCtD
Levocabastine—Erythema—Bimatoprost—glaucoma	0.00246	0.00285	CcSEcCtD
Levocabastine—Pain—Carbachol—glaucoma	0.00243	0.00281	CcSEcCtD
Levocabastine—Visual impairment—Brimonidine—glaucoma	0.00241	0.00279	CcSEcCtD
Levocabastine—NTSR2—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.0024	0.0176	CbGpPWpGaD
Levocabastine—Pain—Levobunolol—glaucoma	0.00239	0.00277	CcSEcCtD
Levocabastine—Somnolence—Methazolamide—glaucoma	0.00238	0.00276	CcSEcCtD
Levocabastine—Pharyngitis—Dorzolamide—glaucoma	0.00237	0.00275	CcSEcCtD
Levocabastine—Pharyngitis—Travoprost—glaucoma	0.00236	0.00274	CcSEcCtD
Levocabastine—Pharyngitis—Brinzolamide—glaucoma	0.00233	0.0027	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—OPN4—glaucoma	0.00232	0.017	CbGpPWpGaD
Levocabastine—NTSR2—Peptide ligand-binding receptors—C3—glaucoma	0.00232	0.017	CbGpPWpGaD
Levocabastine—Dyspnoea—Latanoprost—glaucoma	0.00231	0.00267	CcSEcCtD
Levocabastine—Fatigue—Methazolamide—glaucoma	0.00231	0.00267	CcSEcCtD
Levocabastine—Visual impairment—Dorzolamide—glaucoma	0.0023	0.00267	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—PTGFR—glaucoma	0.0023	0.0169	CbGpPWpGaD
Levocabastine—Visual impairment—Travoprost—glaucoma	0.00229	0.00266	CcSEcCtD
Levocabastine—Asthenia—Metipranolol—glaucoma	0.00229	0.00265	CcSEcCtD
Levocabastine—Visual impairment—Brinzolamide—glaucoma	0.00226	0.00262	CcSEcCtD
Levocabastine—Pharyngitis—Pilocarpine—glaucoma	0.00224	0.0026	CcSEcCtD
Levocabastine—Pain—Latanoprost—glaucoma	0.00222	0.00257	CcSEcCtD
Levocabastine—Erythema—Brimonidine—glaucoma	0.00218	0.00252	CcSEcCtD
Levocabastine—Visual impairment—Pilocarpine—glaucoma	0.00218	0.00252	CcSEcCtD
Levocabastine—Cough—Bimatoprost—glaucoma	0.00215	0.00249	CcSEcCtD
Levocabastine—Asthenia—Carteolol—glaucoma	0.00212	0.00246	CcSEcCtD
Levocabastine—Dry mouth—Apraclonidine—glaucoma	0.00211	0.00245	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—PTGFR—glaucoma	0.00209	0.0153	CbGpPWpGaD
Levocabastine—Asthenia—Diclofenamide—glaucoma	0.00209	0.00241	CcSEcCtD
Levocabastine—Erythema—Dorzolamide—glaucoma	0.00208	0.00241	CcSEcCtD
Levocabastine—Erythema—Travoprost—glaucoma	0.00207	0.0024	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—SMO—glaucoma	0.00205	0.015	CbGpPWpGaD
Levocabastine—Eye pain—Timolol—glaucoma	0.00205	0.00238	CcSEcCtD
Levocabastine—Dry mouth—Bimatoprost—glaucoma	0.00205	0.00237	CcSEcCtD
Levocabastine—Erythema—Brinzolamide—glaucoma	0.00205	0.00237	CcSEcCtD
Levocabastine—Rash—Metipranolol—glaucoma	0.00201	0.00233	CcSEcCtD
Levocabastine—Dermatitis—Metipranolol—glaucoma	0.00201	0.00233	CcSEcCtD
Levocabastine—Asthenia—Levobunolol—glaucoma	0.002	0.00232	CcSEcCtD
Levocabastine—Headache—Metipranolol—glaucoma	0.002	0.00232	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—LRP12—glaucoma	0.00198	0.0145	CbGpPWpGaD
Levocabastine—Visual disturbance—Timolol—glaucoma	0.00196	0.00227	CcSEcCtD
Levocabastine—Asthenia—Methazolamide—glaucoma	0.00192	0.00222	CcSEcCtD
Levocabastine—Cough—Brimonidine—glaucoma	0.0019	0.0022	CcSEcCtD
Levocabastine—Nausea—Metipranolol—glaucoma	0.0019	0.0022	CcSEcCtD
Levocabastine—Headache—Carteolol—glaucoma	0.00185	0.00214	CcSEcCtD
Levocabastine—Dyspnoea—Apraclonidine—glaucoma	0.00185	0.00214	CcSEcCtD
Levocabastine—Somnolence—Apraclonidine—glaucoma	0.00184	0.00213	CcSEcCtD
Levocabastine—Rash—Diclofenamide—glaucoma	0.00183	0.00212	CcSEcCtD
Levocabastine—Headache—Diclofenamide—glaucoma	0.00182	0.00211	CcSEcCtD
Levocabastine—Cough—Dorzolamide—glaucoma	0.00182	0.0021	CcSEcCtD
Levocabastine—Dry mouth—Brimonidine—glaucoma	0.00181	0.0021	CcSEcCtD
Levocabastine—Cough—Travoprost—glaucoma	0.00181	0.00209	CcSEcCtD
Levocabastine—Dyspnoea—Bimatoprost—glaucoma	0.00179	0.00207	CcSEcCtD
Levocabastine—Rash—Carbachol—glaucoma	0.00179	0.00207	CcSEcCtD
Levocabastine—Dermatitis—Carbachol—glaucoma	0.00179	0.00207	CcSEcCtD
Levocabastine—Fatigue—Apraclonidine—glaucoma	0.00179	0.00207	CcSEcCtD
Levocabastine—Somnolence—Bimatoprost—glaucoma	0.00178	0.00207	CcSEcCtD
Levocabastine—Cough—Brinzolamide—glaucoma	0.00178	0.00207	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00178	0.013	CbGpPWpGaD
Levocabastine—Headache—Carbachol—glaucoma	0.00178	0.00206	CcSEcCtD
Levocabastine—Pain—Apraclonidine—glaucoma	0.00177	0.00205	CcSEcCtD
Levocabastine—Nausea—Carteolol—glaucoma	0.00176	0.00203	CcSEcCtD
Levocabastine—Headache—Levobunolol—glaucoma	0.00175	0.00203	CcSEcCtD
Levocabastine—Dry mouth—Dorzolamide—glaucoma	0.00173	0.00201	CcSEcCtD
Levocabastine—Nausea—Diclofenamide—glaucoma	0.00173	0.002	CcSEcCtD
Levocabastine—Dry mouth—Travoprost—glaucoma	0.00172	0.002	CcSEcCtD
Levocabastine—Pain—Bimatoprost—glaucoma	0.00172	0.00199	CcSEcCtD
Levocabastine—Cough—Pilocarpine—glaucoma	0.00172	0.00199	CcSEcCtD
Levocabastine—Dry mouth—Brinzolamide—glaucoma	0.0017	0.00197	CcSEcCtD
Levocabastine—Rash—Methazolamide—glaucoma	0.00169	0.00195	CcSEcCtD
Levocabastine—Dermatitis—Methazolamide—glaucoma	0.00169	0.00195	CcSEcCtD
Levocabastine—Nausea—Carbachol—glaucoma	0.00168	0.00195	CcSEcCtD
Levocabastine—Headache—Methazolamide—glaucoma	0.00168	0.00194	CcSEcCtD
Levocabastine—Nausea—Levobunolol—glaucoma	0.00166	0.00192	CcSEcCtD
Levocabastine—Somnolence—Acetazolamide—glaucoma	0.00165	0.00191	CcSEcCtD
Levocabastine—Rash—Latanoprost—glaucoma	0.00163	0.00189	CcSEcCtD
Levocabastine—Dermatitis—Latanoprost—glaucoma	0.00163	0.00189	CcSEcCtD
Levocabastine—Headache—Latanoprost—glaucoma	0.00162	0.00188	CcSEcCtD
Levocabastine—Fatigue—Acetazolamide—glaucoma	0.0016	0.00185	CcSEcCtD
Levocabastine—Nausea—Methazolamide—glaucoma	0.00159	0.00184	CcSEcCtD
Levocabastine—Dyspnoea—Brimonidine—glaucoma	0.00158	0.00184	CcSEcCtD
Levocabastine—Somnolence—Brimonidine—glaucoma	0.00158	0.00183	CcSEcCtD
Levocabastine—Erythema—Clonidine—glaucoma	0.00157	0.00182	CcSEcCtD
Levocabastine—Pharyngitis—Betaxolol—glaucoma	0.00156	0.0018	CcSEcCtD
Levocabastine—NTSR2—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.00155	0.0114	CbGpPWpGaD
Levocabastine—Fatigue—Brimonidine—glaucoma	0.00153	0.00178	CcSEcCtD
Levocabastine—Pain—Brimonidine—glaucoma	0.00152	0.00176	CcSEcCtD
Levocabastine—Dyspnoea—Dorzolamide—glaucoma	0.00151	0.00175	CcSEcCtD
Levocabastine—Visual impairment—Betaxolol—glaucoma	0.00151	0.00175	CcSEcCtD
Levocabastine—Somnolence—Dorzolamide—glaucoma	0.00151	0.00175	CcSEcCtD
Levocabastine—Dyspnoea—Travoprost—glaucoma	0.00151	0.00175	CcSEcCtD
Levocabastine—Dyspnoea—Brinzolamide—glaucoma	0.00149	0.00172	CcSEcCtD
Levocabastine—Asthenia—Apraclonidine—glaucoma	0.00149	0.00172	CcSEcCtD
Levocabastine—Somnolence—Brinzolamide—glaucoma	0.00148	0.00172	CcSEcCtD
Levocabastine—Fatigue—Dorzolamide—glaucoma	0.00146	0.0017	CcSEcCtD
Levocabastine—Fatigue—Travoprost—glaucoma	0.00146	0.00169	CcSEcCtD
Levocabastine—Pain—Dorzolamide—glaucoma	0.00145	0.00168	CcSEcCtD
Levocabastine—Pain—Travoprost—glaucoma	0.00145	0.00167	CcSEcCtD
Levocabastine—Asthenia—Bimatoprost—glaucoma	0.00144	0.00167	CcSEcCtD
Levocabastine—Fatigue—Brinzolamide—glaucoma	0.00144	0.00167	CcSEcCtD
Levocabastine—Dyspnoea—Pilocarpine—glaucoma	0.00143	0.00166	CcSEcCtD
Levocabastine—Pain—Brinzolamide—glaucoma	0.00143	0.00165	CcSEcCtD
Levocabastine—Somnolence—Pilocarpine—glaucoma	0.00143	0.00165	CcSEcCtD
Levocabastine—Pain—Pilocarpine—glaucoma	0.00137	0.00159	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—OPN4—glaucoma	0.00137	0.01	CbGpPWpGaD
Levocabastine—Cough—Clonidine—glaucoma	0.00137	0.00159	CcSEcCtD
Levocabastine—Erythema—Betaxolol—glaucoma	0.00137	0.00158	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—OPN4—glaucoma	0.00136	0.00996	CbGpPWpGaD
Levocabastine—NTSR2—GPCR ligand binding—EDN1—glaucoma	0.00135	0.00991	CbGpPWpGaD
Levocabastine—Asthenia—Acetazolamide—glaucoma	0.00133	0.00154	CcSEcCtD
Levocabastine—Dry mouth—Clonidine—glaucoma	0.00131	0.00151	CcSEcCtD
Levocabastine—Dermatitis—Apraclonidine—glaucoma	0.0013	0.00151	CcSEcCtD
Levocabastine—Headache—Apraclonidine—glaucoma	0.0013	0.0015	CcSEcCtD
Levocabastine—Asthenia—Brimonidine—glaucoma	0.00128	0.00148	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—HEYL—glaucoma	0.00128	0.00934	CbGpPWpGaD
Levocabastine—Rash—Bimatoprost—glaucoma	0.00127	0.00147	CcSEcCtD
Levocabastine—Dermatitis—Bimatoprost—glaucoma	0.00126	0.00146	CcSEcCtD
Levocabastine—Headache—Bimatoprost—glaucoma	0.00126	0.00146	CcSEcCtD
Levocabastine—Visual impairment—Timolol—glaucoma	0.00124	0.00143	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—PTGFR—glaucoma	0.00123	0.00904	CbGpPWpGaD
Levocabastine—Nausea—Apraclonidine—glaucoma	0.00123	0.00142	CcSEcCtD
Levocabastine—HRH1—G alpha (q) signalling events—PTGFR—glaucoma	0.00123	0.00897	CbGpPWpGaD
Levocabastine—Asthenia—Dorzolamide—glaucoma	0.00122	0.00141	CcSEcCtD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—OPN4—glaucoma	0.00122	0.00891	CbGpPWpGaD
Levocabastine—Asthenia—Travoprost—glaucoma	0.00121	0.0014	CcSEcCtD
Levocabastine—Asthenia—Brinzolamide—glaucoma	0.0012	0.00139	CcSEcCtD
Levocabastine—Cough—Betaxolol—glaucoma	0.00119	0.00138	CcSEcCtD
Levocabastine—Nausea—Bimatoprost—glaucoma	0.00119	0.00138	CcSEcCtD
Levocabastine—NTSR2—GPCR ligand binding—C3—glaucoma	0.00118	0.00866	CbGpPWpGaD
Levocabastine—Headache—Acetazolamide—glaucoma	0.00116	0.00134	CcSEcCtD
Levocabastine—Asthenia—Pilocarpine—glaucoma	0.00115	0.00133	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00115	0.00842	CbGpPWpGaD
Levocabastine—Dyspnoea—Clonidine—glaucoma	0.00114	0.00132	CcSEcCtD
Levocabastine—Somnolence—Clonidine—glaucoma	0.00114	0.00132	CcSEcCtD
Levocabastine—Dry mouth—Betaxolol—glaucoma	0.00114	0.00132	CcSEcCtD
Levocabastine—Rash—Brimonidine—glaucoma	0.00112	0.0013	CcSEcCtD
Levocabastine—Dermatitis—Brimonidine—glaucoma	0.00112	0.0013	CcSEcCtD
Levocabastine—Erythema—Timolol—glaucoma	0.00112	0.00129	CcSEcCtD
Levocabastine—Headache—Brimonidine—glaucoma	0.00111	0.00129	CcSEcCtD
Levocabastine—Fatigue—Clonidine—glaucoma	0.0011	0.00128	CcSEcCtD
Levocabastine—Nausea—Acetazolamide—glaucoma	0.0011	0.00127	CcSEcCtD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PTGFR—glaucoma	0.0011	0.00802	CbGpPWpGaD
Levocabastine—Pain—Clonidine—glaucoma	0.0011	0.00127	CcSEcCtD
Levocabastine—Rash—Dorzolamide—glaucoma	0.00107	0.00124	CcSEcCtD
Levocabastine—Dermatitis—Dorzolamide—glaucoma	0.00107	0.00124	CcSEcCtD
Levocabastine—Rash—Travoprost—glaucoma	0.00107	0.00123	CcSEcCtD
Levocabastine—Dermatitis—Travoprost—glaucoma	0.00106	0.00123	CcSEcCtD
Levocabastine—Headache—Dorzolamide—glaucoma	0.00106	0.00123	CcSEcCtD
Levocabastine—Headache—Travoprost—glaucoma	0.00106	0.00123	CcSEcCtD
Levocabastine—Nausea—Brimonidine—glaucoma	0.00106	0.00122	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—SMO—glaucoma	0.00105	0.00772	CbGpPWpGaD
Levocabastine—Rash—Brinzolamide—glaucoma	0.00105	0.00122	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00105	0.0077	CbGpPWpGaD
Levocabastine—Dermatitis—Brinzolamide—glaucoma	0.00105	0.00122	CcSEcCtD
Levocabastine—Headache—Brinzolamide—glaucoma	0.00105	0.00121	CcSEcCtD
Levocabastine—Rash—Pilocarpine—glaucoma	0.00101	0.00117	CcSEcCtD
Levocabastine—Dermatitis—Pilocarpine—glaucoma	0.00101	0.00117	CcSEcCtD
Levocabastine—Nausea—Dorzolamide—glaucoma	0.00101	0.00117	CcSEcCtD
Levocabastine—Headache—Pilocarpine—glaucoma	0.00101	0.00116	CcSEcCtD
Levocabastine—Nausea—Travoprost—glaucoma	0.001	0.00116	CcSEcCtD
Levocabastine—Dyspnoea—Betaxolol—glaucoma	0.000994	0.00115	CcSEcCtD
Levocabastine—Nausea—Brinzolamide—glaucoma	0.000991	0.00115	CcSEcCtD
Levocabastine—Cough—Timolol—glaucoma	0.000974	0.00113	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—RPTOR—glaucoma	0.000966	0.00707	CbGpPWpGaD
Levocabastine—Fatigue—Betaxolol—glaucoma	0.000962	0.00111	CcSEcCtD
Levocabastine—Pain—Betaxolol—glaucoma	0.000954	0.0011	CcSEcCtD
Levocabastine—Nausea—Pilocarpine—glaucoma	0.000953	0.0011	CcSEcCtD
Levocabastine—HRH1—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.000947	0.00693	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NCK2—glaucoma	0.000936	0.00685	CbGpPWpGaD
Levocabastine—Dry mouth—Timolol—glaucoma	0.00093	0.00108	CcSEcCtD
Levocabastine—Asthenia—Clonidine—glaucoma	0.000919	0.00106	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.000901	0.0066	CbGpPWpGaD
Levocabastine—HRH1—IL-4 Signaling Pathway—BAD—glaucoma	0.000834	0.0061	CbGpPWpGaD
Levocabastine—Dyspnoea—Timolol—glaucoma	0.000812	0.000941	CcSEcCtD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.000811	0.00594	CbGpPWpGaD
Levocabastine—Somnolence—Timolol—glaucoma	0.00081	0.000938	CcSEcCtD
Levocabastine—Rash—Clonidine—glaucoma	0.000808	0.000936	CcSEcCtD
Levocabastine—Dermatitis—Clonidine—glaucoma	0.000807	0.000935	CcSEcCtD
Levocabastine—Headache—Clonidine—glaucoma	0.000803	0.00093	CcSEcCtD
Levocabastine—Asthenia—Betaxolol—glaucoma	0.0008	0.000927	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—HDAC9—glaucoma	0.000796	0.00583	CbGpPWpGaD
Levocabastine—Fatigue—Timolol—glaucoma	0.000786	0.00091	CcSEcCtD
Levocabastine—Pain—Timolol—glaucoma	0.000779	0.000902	CcSEcCtD
Levocabastine—NTSR2—GPCR downstream signaling—EDN1—glaucoma	0.000765	0.0056	CbGpPWpGaD
Levocabastine—Nausea—Clonidine—glaucoma	0.000761	0.000881	CcSEcCtD
Levocabastine—Rash—Betaxolol—glaucoma	0.000703	0.000815	CcSEcCtD
Levocabastine—Dermatitis—Betaxolol—glaucoma	0.000703	0.000814	CcSEcCtD
Levocabastine—Headache—Betaxolol—glaucoma	0.000699	0.000809	CcSEcCtD
Levocabastine—NTSR2—Signaling by GPCR—EDN1—glaucoma	0.000695	0.00509	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—OPN4—glaucoma	0.000686	0.00502	CbGpPWpGaD
Levocabastine—NTSR2—GPCR downstream signaling—C3—glaucoma	0.000669	0.00489	CbGpPWpGaD
Levocabastine—Nausea—Betaxolol—glaucoma	0.000663	0.000767	CcSEcCtD
Levocabastine—Asthenia—Timolol—glaucoma	0.000654	0.000757	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—SMO—glaucoma	0.000623	0.00456	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—PTGFR—glaucoma	0.000618	0.00452	CbGpPWpGaD
Levocabastine—NTSR2—Signaling by GPCR—C3—glaucoma	0.000607	0.00444	CbGpPWpGaD
Levocabastine—Rash—Timolol—glaucoma	0.000575	0.000665	CcSEcCtD
Levocabastine—Dermatitis—Timolol—glaucoma	0.000574	0.000665	CcSEcCtD
Levocabastine—Headache—Timolol—glaucoma	0.000571	0.000661	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NTRK2—glaucoma	0.00057	0.00417	CbGpPWpGaD
Levocabastine—Nausea—Timolol—glaucoma	0.000541	0.000627	CcSEcCtD
Levocabastine—NTSR2—Signaling Pathways—NGFR—glaucoma	0.000489	0.00358	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NTRK1—glaucoma	0.000464	0.0034	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN2B—glaucoma	0.000428	0.00313	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—EDN1—glaucoma	0.000411	0.00301	CbGpPWpGaD
Levocabastine—HRH1—G alpha (q) signalling events—EDN1—glaucoma	0.000407	0.00298	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—OPN4—glaucoma	0.000388	0.00284	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NGF—glaucoma	0.000377	0.00276	CbGpPWpGaD
Levocabastine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—glaucoma	0.000364	0.00267	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—C3—glaucoma	0.000359	0.00263	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—OPN4—glaucoma	0.000352	0.00258	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—PTGFR—glaucoma	0.000349	0.00256	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—APOE—glaucoma	0.000334	0.00244	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CAV1—glaucoma	0.000331	0.00242	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—PTGFR—glaucoma	0.000317	0.00232	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—FN1—glaucoma	0.000315	0.00231	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—SMO—glaucoma	0.000312	0.00228	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—BAD—glaucoma	0.000311	0.00228	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—LRP12—glaucoma	0.0003	0.0022	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.00027	0.00197	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—NOS3—glaucoma	0.00025	0.00183	CbGpPWpGaD
Levocabastine—HRH1—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000236	0.00173	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—CDKN1B—glaucoma	0.000217	0.00159	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—OPN4—glaucoma	0.000208	0.00152	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—EDN1—glaucoma	0.000205	0.0015	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—MMP9—glaucoma	0.000201	0.00147	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HEYL—glaucoma	0.000193	0.00142	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—PTGFR—glaucoma	0.000187	0.00137	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—VEGFA—glaucoma	0.00018	0.00132	CbGpPWpGaD
Levocabastine—HRH1—GPCR ligand binding—C3—glaucoma	0.000179	0.00131	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—SMO—glaucoma	0.00016	0.00117	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—RPTOR—glaucoma	0.000147	0.00107	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NCK2—glaucoma	0.000142	0.00104	CbGpPWpGaD
Levocabastine—NTSR2—Signaling Pathways—TP53—glaucoma	0.000136	0.000997	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—HDAC9—glaucoma	0.000121	0.000884	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—EDN1—glaucoma	0.000116	0.00085	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—EDN1—glaucoma	0.000105	0.000772	CbGpPWpGaD
Levocabastine—HRH1—GPCR downstream signaling—C3—glaucoma	0.000101	0.000742	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—SMO—glaucoma	9.45e-05	0.000692	CbGpPWpGaD
Levocabastine—HRH1—Signaling by GPCR—C3—glaucoma	9.21e-05	0.000674	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK2—glaucoma	8.64e-05	0.000632	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NGFR—glaucoma	7.41e-05	0.000543	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NTRK1—glaucoma	7.04e-05	0.000516	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN2B—glaucoma	6.49e-05	0.000475	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—EDN1—glaucoma	6.23e-05	0.000456	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NGF—glaucoma	5.72e-05	0.000419	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—C3—glaucoma	5.44e-05	0.000398	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—APOE—glaucoma	5.06e-05	0.000371	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CAV1—glaucoma	5.02e-05	0.000367	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—FN1—glaucoma	4.78e-05	0.00035	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—BAD—glaucoma	4.72e-05	0.000346	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—NOS3—glaucoma	3.79e-05	0.000278	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—CDKN1B—glaucoma	3.29e-05	0.000241	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—MMP9—glaucoma	3.04e-05	0.000223	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—VEGFA—glaucoma	2.73e-05	0.0002	CbGpPWpGaD
Levocabastine—HRH1—Signaling Pathways—TP53—glaucoma	2.07e-05	0.000151	CbGpPWpGaD
